Analysis of Gynecologic Cancer Management at Sanglah Hospital during COVID- 19 Pandemic

The COVID-19 pandemic presents its own challenges in treating cancer, especially gynecological cancer. The condition of cancer patients who have been immunocompromised either because of their disease or side effects of the drugs given, has the potential to increase the risk of cancer patients to experience severe COVID-19 infection. The main management of cancer, which is based on three axes, namely surgery, chemotherapy, and radiotherapy, needs to be adapted to increase survival rates. rates in patients. Keywords: COVID-19, chemotherapy, gynecological cancer, operative, radiotherapy.